tiprankstipranks
Trending News
More News >
Leonardo DRS (DRS)
NASDAQ:DRS
Advertisement

Leonardo Drs (DRS) AI Stock Analysis

Compare
970 Followers

Top Page

DRS

Leonardo Drs

(NASDAQ:DRS)

Rating:68Neutral
Price Target:
$45.00
▲(9.65% Upside)
Leonardo DRS's overall stock score is driven by strong financial performance and positive earnings call insights, highlighting growth potential and strategic opportunities. However, technical analysis indicates bearish momentum, and the high P/E ratio suggests potential overvaluation, which tempers the overall score.
Positive Factors
Financial performance
DRS' 1Q25 earnings beat marks a strong start to the year.
Geopolitical environment
The current dynamic geopolitical backdrop is highly favorable to DRS.
Shipbuilding and defense modernization
The renewed emphasis on shipbuilding, coupled with continued strong defense tech modernization spending globally, is incrementally positive for DRS.
Negative Factors
Material pricing
Increased material pricing may be a slight headwind to DRS as their safety stock of Germanium dwindles.
Supply chain risks
The supply and refinement of Germanium is a key watch item due to tensions with China, which may pose a slight headwind.

Leonardo Drs (DRS) vs. SPDR S&P 500 ETF (SPY)

Leonardo Drs Business Overview & Revenue Model

Company DescriptionLeonardo DRS (DRS) is a leading provider of advanced technology solutions for the defense, security, and commercial markets. The company operates primarily in two sectors: Defense Systems and Commercial Products. Its core offerings include a wide range of products such as electronic warfare systems, sensor solutions, and power and thermal management technologies, which are critical for military and aerospace applications. DRS is dedicated to delivering innovative technologies that enhance the operational effectiveness and safety of its customers.
How the Company Makes MoneyLeonardo DRS generates revenue primarily through government contracts and defense procurement, providing systems and solutions to the U.S. Department of Defense and allied nations. Key revenue streams include the sale of defense electronics, logistics support, and integrated systems that enhance military capabilities. Additionally, the company engages in partnerships with other defense contractors and technology firms to develop joint solutions, which can expand its market reach and enhance the value of its offerings. Contracts often include multi-year agreements, allowing for a stable revenue flow, while ongoing maintenance and support services contribute to recurring income.

Leonardo Drs Earnings Call Summary

Earnings Call Date:Jul 30, 2025
(Q2-2025)
|
% Change Since: -14.66%|
Next Earnings Date:Oct 30, 2025
Earnings Call Sentiment Positive
The earnings call highlighted strong financial performance with significant revenue and profitability growth, driven by robust bookings and backlog. The positive defense funding environment provides additional opportunities for growth. However, challenges such as germanium supply constraints and trade risks present potential headwinds. Overall, the positive aspects outweigh the challenges.
Q2-2025 Updates
Positive Updates
Strong Bookings and Backlog Growth
Secured $853 million in bookings with a 1.0 book-to-bill ratio for the quarter, and a total backlog of $8.6 billion, which is a 9% year-over-year increase.
Increased Revenue Growth Expectations
Increased full-year revenue growth expectations to 9% to 11%, with solid double-digit organic revenue growth.
Profitability and Margin Expansion
Adjusted EBITDA increased by 17%, margin expanded by 70 basis points, and adjusted diluted EPS was up 28%.
Positive Defense Funding Environment
New legislation includes $150 billion in defense funding with $113 billion front-loaded into FY '26, representing significant opportunities for Leonardo DRS, Inc.
Strong Performance in Electric Power and Propulsion
The electric power and propulsion segment continues to perform exceptionally well, contributing to top-line growth and margin expansion.
Negative Updates
Germanium Supply Chain Challenges
Export restrictions have constrained the global supply of germanium, impacting raw material costs and potentially affecting timely product deliveries.
Tariff and Trade Risks
Potential for retaliatory trade restrictions on critical minerals due to the expiration of a temporary tariff reprieve.
M&A Market Pressures
High interest in the sector has driven up prices, impacting M&A activities and financial criteria for potential acquisitions.
Company Guidance
During the call, Leonardo DRS, Inc. provided guidance for the full fiscal year 2025, anticipating revenue growth between 9% and 11%, translating to a range of $3.525 to $3.6 billion. The company reported a book-to-bill ratio greater than 1.0 for the quarter, with $853 million in bookings and a total backlog of $8.6 billion, marking a 9% year-over-year increase. Adjusted EBITDA for the second quarter rose by 17% to $96 million, with a margin expansion of 70 basis points to 11.6%. Adjusted diluted EPS increased by 28% to $0.23. The company remains focused on executing its strategy amid a complex macro environment, with plans to mitigate germanium supply chain issues by 2026. Additionally, Leonardo DRS, Inc. expects opportunities from the newly enacted One Big Beautiful Bill Act, which includes $150 billion in defense funding, potentially benefiting from initiatives such as shipbuilding and missile defense. The company also noted international sales growth driven by NATO commitments and ongoing geopolitical tensions.

Leonardo Drs Financial Statement Overview

Summary
Leonardo DRS demonstrates strong financial performance with robust revenue and profit growth, effective cost management, and operational efficiency. The balance sheet is stable with low leverage, and cash flow management is solid, indicating financial stability and growth potential.
Income Statement
85
Very Positive
Leonardo DRS shows strong revenue growth with a TTM (Trailing-Twelve-Months) increase of 5.8% compared to previous annual data. Gross profit margin and net profit margin are healthy, indicating effective cost management and profitability. The EBIT margin and EBITDA margin are also robust, further supporting financial health and operational efficiency.
Balance Sheet
78
Positive
The balance sheet reflects solid equity, with a debt-to-equity ratio of 0.14, indicating low financial leverage and a strong equity position. The return on equity is commendable, showcasing effective use of shareholders' funds. The equity ratio suggests a stable asset base, though there is room for improvement in asset efficiency.
Cash Flow
80
Positive
Leonardo DRS demonstrates solid cash flow management with a significant increase in free cash flow over the TTM period. The operating cash flow to net income ratio is favorable, highlighting strong cash generation from operations. Free cash flow to net income ratio is healthy, indicating good cash conversion efficiency.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.42B3.23B2.83B2.69B2.88B2.78B
Gross Profit792.00M736.00M648.00M575.00M547.00M494.00M
EBITDA409.00M376.00M313.00M624.00M293.00M229.00M
Net Income250.00M213.00M168.00M405.00M154.00M85.00M
Balance Sheet
Total Assets4.08B4.18B3.92B3.68B3.07B2.96B
Cash, Cash Equivalents and Short-Term Investments278.00M598.00M467.00M306.00M240.00M61.00M
Total Debt472.00M458.00M497.00M487.00M490.00M530.00M
Total Liabilities1.48B1.63B1.60B1.55B1.48B1.53B
Stockholders Equity2.60B2.56B2.33B2.13B1.59B1.43B
Cash Flow
Free Cash Flow235.00M186.00M145.00M-32.00M118.00M69.00M
Operating Cash Flow336.00M271.00M205.00M33.00M178.00M125.00M
Investing Cash Flow-100.00M-84.00M-59.00M436.00M39.00M-70.00M
Financing Cash Flow-107.00M-56.00M15.00M-403.00M-38.00M-80.00M

Leonardo Drs Technical Analysis

Technical Analysis Sentiment
Negative
Last Price41.04
Price Trends
50DMA
44.58
Negative
100DMA
41.64
Negative
200DMA
37.47
Positive
Market Momentum
MACD
-1.07
Positive
RSI
37.42
Neutral
STOCH
25.88
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DRS, the sentiment is Negative. The current price of 41.04 is below the 20-day moving average (MA) of 42.60, below the 50-day MA of 44.58, and above the 200-day MA of 37.47, indicating a neutral trend. The MACD of -1.07 indicates Positive momentum. The RSI at 37.42 is Neutral, neither overbought nor oversold. The STOCH value of 25.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DRS.

Leonardo Drs Risk Analysis

Leonardo Drs disclosed 55 risk factors in its most recent earnings report. Leonardo Drs reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Leonardo Drs Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$10.33B27.2512.21%0.09%22.95%-1.01%
77
Outperform
$10.41B19.8811.59%2.00%-1.75%-29.19%
70
Outperform
$15.15B51.7226.97%0.61%10.13%10.04%
68
Neutral
$10.96B44.259.99%0.66%11.43%32.31%
62
Neutral
$8.86B67.097.25%16.09%
60
Neutral
kr43.36B13.661.95%2.33%-0.60%-20.68%
55
Neutral
$19.74B-40.45%54.36%-26.35%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DRS
Leonardo Drs
41.04
12.83
45.48%
ERJ
Embraer SA
56.28
22.63
67.25%
HII
Huntington Ingalls
266.48
-1.19
-0.44%
BWXT
BWX Technologies
165.34
64.10
63.31%
RKLB
Rocket Lab USA
41.53
34.57
496.70%
SARO
StandardAero, Inc.
26.87
-6.10
-18.50%

Leonardo Drs Corporate Events

DividendsFinancial Disclosures
Leonardo DRS Reports Strong Q2 2025 Financial Results
Positive
Jul 30, 2025

Leonardo DRS reported strong financial results for the second quarter of 2025, with a 10% increase in revenue to $829 million and a 42% rise in net earnings to $54 million compared to the previous year. The company also announced a $0.09 cash dividend per share to be paid on September 3, 2025, and highlighted its continued focus on disciplined execution amidst a dynamic macroeconomic environment. The results reflect healthy bookings, solid organic revenue growth, and improved profitability driven by increased demand for its advanced technologies.

Shareholder Meetings
Leonardo DRS Stockholders Approve Key Proposals at Meeting
Neutral
Jun 5, 2025

On June 4, 2025, Leonardo DRS held its Annual Meeting where stockholders voted on various proposals. The election of directors saw significant support, with most nominees receiving over 250 million votes in favor. Additionally, the advisory resolution on executive compensation and the ratification of Ernst & Young LLP as the independent auditor were approved. An amendment to the company’s certificate of incorporation to remove certain supermajority voting requirements was also passed.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 20, 2025